Skip to main content

“Evolution” of intravascular leiomyomatosis

Abstract

Background

Intravenous leiomyomatosis (IVL) is a rare and specific type of smooth muscle tumor that is histologically benign but has a malignant biological behavior. It is commonly associated with a history of uterine leiomyomas.

Case presentation

A 36-year-old woman, G1P1, presented to the hospital with left lower abdominal pain for 2 months and she has accepted hysteroscopic myomectomy about 1 year ago. Ultrasound venography, echocardiography and computed tomography venography (CTV) of inferior vena cava were performed, which revealed IVL located in left intramural myometrium walls growing along the left ovarian vein reaching the level of the lumbar 5-sacral 1 disc. Laparoscopic bilateral salpingo-oophorectomy and hysterectomyis were scheduled. The IVL in the left ovarian vein and parauterine venous plexus were detected and excised completely during surgery. IVL was diagnosed by postoperative pathology and immunohistochemistry. The patient recovered well after surgery. No surgical-related or anesthesia-related complications occurred.The 3-month follow-up CTV of inferior vena cava and echocardiography examination revealed normal.

Conclusions

The cause of IVL is unknown, this observation demonstrates that hysteroscopic myomectomy might lead to the occurrence of IVL.

Peer Review reports

Background

Intravenous leiomyomatosis (IVL) is a rare and specific type of smooth muscle tumor that is characterized by the presence of vascular extension and invasion of benign smooth muscle lesions in a worm-like manner into the pelvic and systemic vasculature system [1, 2]. The incidence of IVL is low and the specific pathogenesis is still unclear. However, most studies believe that the tumor originates in the uterus, spread along the intra- and extrauterine venous lumen and can extend to the inferior vena cava, right atrium, right ventricle, and pulmonary artery [3]. About 83.5–94.3% of IVL patients had uterine fibroids or previous history of uterine fibroid surgery as reported [4, 5]. This disease may remain hidden and the clinical manifestations in early-stage patients are non-specific and it is easy to be misdiagnosed or missed. Since IVL is aggressive and it’s atypical symptoms, early recognition and management can prevent fatal consequences. Patients with a history of uterine fibroids or surgery should request scheduled follow-up for early detection and treatment.

Case presentation

A 36-year-old woman, G1P1, presented to the hospital with left lower abdominal pain for 2 months. She had accepted hysteroscopic myomectomy for menorrhagia and anemia caused by submucosal fibroid (FIGO classification:type 1, measuring 4 cm in diameter by ultrasonography) about 1 year ago. During the operation, the fibroid was soft, round and hernia-like with rich blood supply. The myoma was completely resected by hysteroscopy, and all symptoms disappeared.The ultrasound examination found no abnormality 1-month post-surgery. During follow-up, ultrasound examination revealed a low echo mass with rich blood supply located in left intramural myometrium walls where the previous operation site was, and gradually increased form approximately 2.5 to 4 cm in diameter at 5 and 8 months.Until this admission, we gave her GNRH-a injection 3 times(3.75 mg/28days), but the mass grew out of the uterus,growing along the left ovarian vein reaching the level of the lumbar 5-sacral 1 disc, and ultrasound venography indicated it’s intravenous leiomyomatosis(IVL). Echocardiography and computed tomography venography (CTV) of inferior vena cava were performed and showed heart and other blood vessels with no abnormality. Laparoscopic bilateral salpingo-oophorectomy and hysterectomyis were scheduled.

During this surgical operation, the uterus looked normal size, with a uneven surface, and the cord-like tissues in the left ovarian vessel was detected. During the hysterectomy, many rope and mass-like muscle tissues surrounding with abnormal proliferation blood vessels in the left inferior uterine body to the cervix were observed, and was closely related to the left ureter and the left lateral wall of the bladder.The IVL in the left ovarian vein and parauterine venous plexus were excised completely during surgery(Fig. 1 Fig. 2 ). The post-operative histopathological results confirmed uterine leiomyoma and IVL (Fig. 3). The lesions of IVL was completely resected by laparoscopy, thereby successfully blocking the progression of the lesions to cardio-pulmonary vascular which may endanger the patient’s life.The patient recovered well after surgery.No surgical-related or anesthesia-related complications occurred.The 3-month follow-up CTV of inferior vena cava and echocardiography examination revealed normal.

Fig. 1
figure 1

The IVL in the left ovarian vein

Fig. 2
figure 2

The IVL in the left parauterine venous plexus

Fig. 3
figure 3

Histopathological results confirmed intravenous leiomyomatosis

Discussion

Intravascular leiomyomatosis (IVL) is a histologically-benign, rare mesenchymal tumor which can develop from the veins of the uterus, extend into the inferior vena cava and ultimately into the right side of the heart, resulting in death.The aetiology of IVL is unclear and discussion centres around two hypothesis, namely,the proliferation of vascular smooth muscle cells and the direct invasion of uterine leiomyoma into the muscular veins and diffusion along the vascular lumen [6, 7].According to the reported cases, about 83. 5-94.3% of IVL patients had uterine fibroids or previous history of uterine fibroid surgery as reported [4, 5], so most scholars believe that IVL is caused by uterine leiomyoma directly invading the veins of myometrium. Chen et al. analyzed the clinical data of 361 IVL patients(38 patients from Qilu Hospital of Shandong University and 323 patients from the published literature) and confirmed the hypothesis that IVL originates from the uterus to a certain extent [8]. Similarly, Van et al. found that the estrogen and progesterone receptor in IVL cells were weakly positive to strongly positive, while normal vascular smooth muscle cells were often negative or weakly positive, also confirming that IVL originated in the uterus [9]. The patient we report here obtained IVL after hysteroscopic myomatectomy. In addition, imaging examination, intraoperative exploration and postoperative pathology all indicated that IVL was connected to the uterus, which also supported this theory. Therefore, we have reason to believe that our patient’s IVL was derived from a previous submucosal myoma.

At present, the management guidelines for IVL is unavailable, and the current treatment is mainly based on limited case reports. According to previous reports, the postoperative recurrence rate is high after incomplete tumor resection, approximately 16.6–30.0% [10]. The preferred treatment for IVL is surgery with radical tumour resection to reduce the risk of disease progression and future recurrence [11]. The specific surgical strategies and approaches should be combined with the staging and invasion range of the tumor. In our patient, the tumor was found to grow upward along the left ovarian vein during follow-up, and the patient received laparoscopic surgery timely. The IVL in the left ovarian vein and parauterine venous plexus were detected and excised completely during surgery. The lesions of IVL was completely resected by laparoscopy, thereby successfully blocking the progression of the lesions to cardio-pulmonary vascular which may endanger the patient’s life.The patient recovered well after surgery.No new lesions were found during the 3-month follow-up.

Conclusions

We report a case of IVL that progressed after submucosal myomectomy. The cause of IVL is unknown, this observation demonstrates that hysteroscopic myomectomy might lead to the occurrence of IVL. Due to the rarity of IVL, most current research is limited to case reports. Nevertheless, case report is limited by the quality of information available. Systematic literature review or multi-center studies about IVL is beneficial to increased awareness on the etiology and treatment of IVL. In addition, up to now, the present case has been followed up for only several months and reported no recurrence. It is possibly because the follow-up time was short, which needs to continue for life. Early detection and accurate diagnosis are imperative for appropriate treatment.

Data Availability

All data generated or analyzed during this study are included in this published article.

Abbreviations

IVL:

intravenous leiomyomatosis

CTV:

Computed tomography venography

References

  1. Brescia RJ, Tazelaar HD, Hobbs J, Miller AW. Intravascular lipoleiomyomatosis: a report of two cases. Hum Pathol. 1989;20(3):252–6.

    Article  CAS  PubMed  Google Scholar 

  2. Clement PB, Young RH, Scully RE. Intravenous leiomyomatosis of the uterus. A clinicopathological analysis of 16 cases with unusual histologic features. Am J Surg Pathol. 1988;12(12):932–45.

    Article  CAS  PubMed  Google Scholar 

  3. Norris HJ, Parmley T. Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis: a clinical and pathologic study of 14 cases. Cancer. 1975;36:2164–78.

    Article  CAS  PubMed  Google Scholar 

  4. Li B, Chen X, Chu YD, et al. Intracardiac leiomyomatosis: a comprehensive analysis of 194 cases. Interact Card- iovasc Thorac Surg. 2013;17(1):132–8.

    Article  Google Scholar 

  5. Lan S, Wang X, Li Y, Zhai M. Intravenous leiomyomatosis: a case study and literature review. Radiol Case Rep. 2022;17(11):4203–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Han Y, Chung YJ, Shin I, Park JY, Shim S, Hijazi A, Song JY, Cho HH, Kim MR. Intravenous leiomyomatosis misdiagnosed with large thrombosis in inferior vena cava. Taiwan J Obstet Gynecol. 2021;60(2):367–9.

    Article  PubMed  Google Scholar 

  7. Lian C, Yin S, Qiu J, Cui J, Hu Z, Chang G, Wang S, Wang J. Experience in the diagnosis and treatment of intravenous leiomyomatosis involving the inferior vena cava and/or right cardiac chambers. J Vasc Surg Venous Lymphat Disord. 2021;9(2):452–60.

    Article  PubMed  Google Scholar 

  8. Chen J, Bu H, Zhang Z, Chu R, Qi G, Zhao C, Wang Q, Ma X, Wu H, Dou Z, Wang X, Kong B. Clinical features and prognostic factors analysis of intravenous leiomyomatosis. Front Surg. 2023;30:9:1020004.

    Article  Google Scholar 

  9. Van Maercke J, Van Rompuy AS, Poppe W, Verbelen T, Delcroix M, Belge C. Intravascular leiomyomatosis as a Rare cause of Nonthrombotic Pulmonary Embolism. Case Rep Vasc Med. 2020;2020:6084061.

    PubMed  PubMed Central  Google Scholar 

  10. Sun R, Guan H, Li H, Bai Y, Wang F, Li C. Computed tomography evaluation of extensive intravenous angioleiomyoma: a case report. BMC Med Imaging. 2020;20(1):13.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Stilidi I, Paianidi J, Bokhian V, Andreeva J, Shevchuk A, Ramirez PT. Intracardiac intravenous leiomyomatosis: diagnosis and management. Int J Gynecol Cancer. 2020;30(8):1243–7.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the participant of our study for sharing her clinical information.

Funding

This study had no funding.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Li Chen and Chengzhi Zhao: Material preparation. Li Chen:Data Collection, outcome follow up, writing-original draft preparation. Yunping Yang:Figure processing. Chengzhi Zhao: Project development, writing-review and editing.All authors read and approved the final manuscript.

Corresponding author

Correspondence to Chengzhi Zhao.

Ethics declarations

Ethics approval and consent to participate

Approval was not requested from the human institutional review board, since the study was a summary of clinical information of the patient what was considered routine management at our hospital. Written informed consent was given and obtained from the patient to publish the case.

Consent for publication

The patient gave written informed consent for the case report to be published.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, L., Yang, Y. & Zhao, C. “Evolution” of intravascular leiomyomatosis. BMC Women's Health 23, 483 (2023). https://doi.org/10.1186/s12905-023-02618-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12905-023-02618-3

Keywords